VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 209 filers reported holding VIR BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $181,244 | -51.0% | 19,343 | +28.3% | 0.00% | -50.0% |
| Q2 2023 | $369,961 | +37.3% | 15,082 | +30.2% | 0.00% | +100.0% |
| Q1 2023 | $269,536 | -12.4% | 11,583 | -4.7% | 0.00% | -50.0% |
| Q4 2022 | $307,694 | +74.8% | 12,157 | +33.2% | 0.00% | +100.0% |
| Q3 2022 | $176,000 | -24.5% | 9,129 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $233,000 | -1.3% | 9,129 | -0.6% | 0.00% | 0.0% |
| Q1 2022 | $236,000 | -33.3% | 9,184 | +8.8% | 0.00% | -50.0% |
| Q4 2021 | $354,000 | +22.1% | 8,444 | +26.7% | 0.00% | 0.0% |
| Q3 2021 | $290,000 | -7.9% | 6,664 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $315,000 | – | 6,664 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $36,281,234 | 32.04% |
| SB INVESTMENT ADVISERS (UK) LTD | 18,319,938 | $426,304,957 | 3.50% |
| Zebra Capital Management LLC | 27,110 | $631 | 3.15% |
| Avidity Partners Management LP | 1,640,200 | $38,167,454 | 1.27% |
| Sofinnova Investments, Inc. | 657,559 | $15,301,398 | 0.98% |
| DCF Advisers, LLC | 62,000 | $1,442,740 | 0.88% |
| SECTOR GAMMA AS | 145,545 | $3,386,832 | 0.82% |
| Temasek Holdings (Private) Ltd | 5,814,972 | $135,314,398 | 0.80% |
| BRAIDWELL LP | 604,036 | $14,055,918 | 0.46% |
| SummerHaven Investment Management, LLC | 26,045 | $606,067 | 0.35% |